Carl Denys Joins ChemImage as Vice President, Medical Devices

Advanced Imaging and Machine Learning Company Taps Medical Device Executive to Lead Expansion in Medical Applications for Patented Technology 

ChemImage, a leader in advanced imaging and machine learning technology, has recruited Carl Denys to its executive management team. Mr. Denys will report to Patrick Treado, Founder and President of ChemImage, where he will focus on identifying expansion opportunities for the company’s patented technology in medical applications.

As a seasoned executive, Mr. Denys has thrived on leading teams at image solution companies EOS Imaging, recently acquired by ATEC, and Deerfield Imaging, as well as the cardiology division of Boston Scientific and St. Jude Medical International Division.  He is a highly strategic and influential decision maker who promotes a customer-focused culture.

“As our business has grown and our focus turns more to solving complex medical challenges, we identified the need to add leadership with strong experience in medical devices,” Treado stated. “Carl comes to us with experience in strategic planning, sales, marketing, and business development with global organizations. We are confident that he will help us to continue to grow in the medical device space.”

Mr. Denys will lead the ChemImage marketing, business development, and product management teams. He will focus on the application of ChemImage technology for diagnostic endoscopy, as well as the CardioVere product that focuses on quantifying pre-clinical congestion in heart failure patients. Additionally, he will identify and seek out other opportunities for application of the technology toward the company’s primary goal of enabling the Awareness of Things® in Life Sciences.

About ChemImage Corporation

ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.

ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics. 

For more information, contact ChemImage.